Pharma News

Japan's Daiichi Sankyo unveils new Toronto headquarters to accelerate investment and innovation in oncology

Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the officia

23 January, 2026 | Friday | News
Taiwan's OBI Pharma inks agreement US-based TegMine Therapeutics for glycan-targeting ADC

Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San

13 January, 2026 | Tuesday | News
Santhera licenses AGAMREE to Japan's Nxera Pharma in $205 M Asia-Pacific deal

Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the d

09 January, 2026 | Friday | News

BioTech News

SK bioscience, MSD, and Hilleman Labs advance Zaire ebolavirus vaccine development

South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vacci

23 January, 2026 | Friday | News
Xellar, Woojung Bio to advance AI-enabled organ-on-a-chip preclinical models

US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligen

08 January, 2026 | Thursday | News
Korea opens door to B cell-based personalised cancer vaccines​

Researchers from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Techno

05 January, 2026 | Monday | News

MedTech News

Sisram Medical partners with Sinmait Medical Technology to build manufacturing hub in China

Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complement

23 January, 2026 | Friday | News
LivsMed completes largest KOSDAQ IPO of 2025, raising ₩135.9 B

LivsMed, a minimally invasive surgical device company, has completed an initial public offering on Korea&rsquo

19 January, 2026 | Monday | News

BioServices News

Korea's GCCL partners with OPIS to advance global clinical trial capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and US-based OPIS, a global full

16 January, 2026 | Friday | News
Rakuten Medical and Lotte Biologics ink agreement to support biopharma in global oncology programme

US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manu

14 January, 2026 | Wednesday | News

Inside Magazine

The Future of mRNA Is Being Built in APAC
Beyond scientific advancement, mRNA represents a strategic opportunity shaped by policy stability, public investment and regional collaboration. Across APAC, governments are increasingly recognising that supportive regulatory frameworks and long-term funding can serve as powerful competitive advantages, attracting global capital and talent. While political dynamics in the United States have slowed momentum, experts emphasise that the science underpinning mRNA technology remains sound. To fully realise its potential, the region will need greater coordination across borders, including regulatory harmonisation and joint development pathways, to build a resilient mRNA ecosystem capable of addressing shared health challenges and driving long-term innovation.

For Feedback, please email us at: communications@mmactiv.com

Click here to access E-magazine

Video Gallery

Events

View All
29 - 31
Jan - 0026

Medical Fair India 2026

Messe Düsseldorf India Pvt. Ltd.

messeduesseldorf@md-india.com https://www.medicalfair-india.com/

Delhi Pragati Maidan, Delhi

24 - 26
Mar - 0026

Dubai International Pharmaceutical & Technology Conference& Exhibition (DUPHAT)

Index Conferences & Exhibitions

info@duphat.ae https://duphat.ae/

Dubai World Trade Center

26 - 28
Oct - 0026

ArabLab 2026 Dubai

Terrapinn Middle East Fz Llc

anne.deguzman@terrapinn.com https://www.terrapinn.com/exhibition/arablab-live/index.stm

Dubai World Trade Centre, Dubai

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls